News

January 4, 2018January 4, 2018

FoxO3 Protein Found to Be Key Regulator of Fibrosis in Lungs, Study Finds

The protein FoxO3, which regulates the levels of other proteins in cells, was found to play a key role in the development of pulmonary fibrosis, researchers reported. Results of the ... Read more

January 3, 2018January 3, 2018

Bristol-Myers Squibb Foundation Awards $2.8M for Lung Cancer Screening, Care Programs in Philadelphia Communities

News

Thomas Jefferson University and Jefferson Health have been awarded $2.8 million from the Bristol-Myers Squibb Foundation to start lung cancer screening, care and prevention programs in underserved communities in Philadelphia. ... Read more

December 22, 2017December 22, 2017

FDA Grants Orphan Drug Status to Pulmonary Fibrosis Therapy Candidate Ryplazim

Idiopathic Pulmonary Fibrosis, News

The U.S. Food and Drug Administration has granted orphan drug status to Ryplazim, an idiopathic pulmonary fibrosis therapy that Prometic Life Sciences is developing. It’s the second time the FDA has designated a Prometic IPF ... Read more

December 21, 2017December 21, 2017

Obesity in Preschoolers Linked to Worse Asthma Symptoms but Good Response to Treatment

Asthma, News

Preschool children who are overweight or obese are likely to have more asthma attacks and disease symptoms than their normal-weight peers, but these children still respond well to treatment with ... Read more

December 20, 2017December 20, 2017

Aggressive Treatment of IPF Patients with Lung Cancer Rarely Best Option, Experts Say

Idiopathic Pulmonary Fibrosis, Lung Cancer, News

A group of clinician-reseachers with expertise in lung diseases suggest in a commentary that people with both idiopathic pulmonary fibrosis (IPF) and lung cancer are best managed with a goal of “first, do ... Read more

December 19, 2017December 19, 2017

Pharmaxis, Synairgen Update Partnership to Advance Potential IPF Treatment in Clinical Trial

Idiopathic Pulmonary Fibrosis, News

Pharmaxis and Synairgen have revised their Lysyl Oxidase type 2 enzyme (LOXL2) program collaboration agreement, after obtaining positive results in preclinical studies and launching a Phase 1 clinical trial. Strong evidence suggests that ... Read more

December 18, 2017December 18, 2017

Genentech’s New Combo Therapy Improves Progression-free Survival in Advanced Non-small Cell Lung Cancer

Lung Cancer, News

Progression-free survival (PFS) was improved in patients with advanced non-squamous non-small cell lung cancer (NSCLC) using a combination of Avastin (bevacizumab), Tecentriq (atezolizumab), and chemotherapy in a Phase 3 clinical ... Read more

December 14, 2017December 14, 2017

Aggressive Surgery Increases Lung Cancer Patients’ Long-term Survival, Study Shows

Lung Cancer, News

A lung surgery called lobectomy increases early lung cancer patients’ long-term survival better than less aggressive surgical approaches or radiation, a study shows. A lobectomy involves removing portions of lungs ... Read more

December 13, 2017December 13, 2017

ALCF, Boehringer Ingelheim Bring Gift of Volunteer Help to Lung Cancer Patients

Lung Cancer, News

The Bonnie J. Addario Lung Cancer Foundation (ALCF) and the employees at Boehringer Ingelheim Pharmaceuticals have joined forces to help brighten the holiday season for lung cancer patients through the “Bring Hope ... Read more